Showing results (1591-1600 of 1,735) with videos related to

Sort By:
Pageof 174
Elife|November 16, 2018
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcomaGerard L Brien, David Remillard, Junwei Shi, et al.
Plos One|July 16, 2021
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia Dee Cesare, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Development and characterization of HPV-positive and HPV-negative head and neck squamous cell carcinoma tumorgraftsRandall J Kimple, Paul M Harari, Alexandra D Torres, et al.
Blood|October 12, 2017
SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemiaBrenton G Mar, S Haihua Chu, Josephine D Kahn, et al.
Cell Stem Cell|December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapyClaudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
The EMBO Journal|January 7, 2005
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative diseaseJing Wang, Hiromi Iwasaki, Andrei Krivtsov, et al.
The Journal of Clinical Investigation|February 16, 2016
MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1CNan Zhu, Mo Chen, Rowena Eng, et al.
Blood|February 18, 2018
LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AMLMonica Cusan, Sheng F Cai, Helai P Mohammad, et al.
Science Signaling|September 15, 2016
Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AMLIsabel Morgado-Palacin, Amanda Day, Matilde Murga, et al.
Pageof 174